BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11495723)

  • 1. MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: a role for the MAP kinase pathway in regulating mitotic exit.
    Willard FS; Crouch MF
    Cell Signal; 2001 Sep; 13(9):653-64. PubMed ID: 11495723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK activation and mitogenesis in human airway smooth muscle cells.
    Lee JH; Johnson PR; Roth M; Hunt NH; Black JL
    Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L1019-29. PubMed ID: 11290527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
    Piatelli MJ; Doughty C; Chiles TC
    J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEK-1/2 inhibition reduces branching morphogenesis and causes mesenchymal cell apoptosis in fetal rat lungs.
    Kling DE; Lorenzo HK; Trbovich AM; Kinane TB; Donahoe PK; Schnitzer JJ
    Am J Physiol Lung Cell Mol Physiol; 2002 Mar; 282(3):L370-8. PubMed ID: 11839529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway.
    Mérienne K; Jacquot S; Zeniou M; Pannetier S; Sassone-Corsi P; Hanauer A
    Oncogene; 2000 Aug; 19(37):4221-9. PubMed ID: 10980595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes.
    Zeigler ME; Chi Y; Schmidt T; Varani J
    J Cell Physiol; 1999 Aug; 180(2):271-84. PubMed ID: 10395297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases.
    Grammer TC; Blenis J
    Oncogene; 1997 Apr; 14(14):1635-42. PubMed ID: 9135064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
    Roux PP; Richards SA; Blenis J
    Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MEK inhibitor U0126 on meiotic progression in mouse oocytes: microtuble organization, asymmetric division and metaphase II arrest.
    Tong C; Fan HY; Chen DY; Song XF; Schatten H; Sun QY
    Cell Res; 2003 Oct; 13(5):375-83. PubMed ID: 14672561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
    Cheng M; Sexl V; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
    Hartkamp J; Troppmair J; Rapp UR
    Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner.
    Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
    Oncogene; 2002 Sep; 21(39):6101-12. PubMed ID: 12203122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase.
    Chiariello M; Gomez E; Gutkind JS
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):869-76. PubMed ID: 10903150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion.
    Jones NC; Fedorov YV; Rosenthal RS; Olwin BB
    J Cell Physiol; 2001 Jan; 186(1):104-15. PubMed ID: 11147804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: a possible role in the regulation of gene expression.
    Kim SJ; Kahn CR
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):621-7. PubMed ID: 9169593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes.
    Engelman JA; Berg AH; Lewis RY; Lisanti MP; Scherer PE
    Mol Endocrinol; 2000 Oct; 14(10):1557-69. PubMed ID: 11043572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis.
    Roberts EC; Shapiro PS; Nahreini TS; Pages G; Pouyssegur J; Ahn NG
    Mol Cell Biol; 2002 Oct; 22(20):7226-41. PubMed ID: 12242299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras.
    Brassard DL; English JM; Malkowski M; Kirschmeier P; Nagabhushan TL; Bishop WR
    Exp Cell Res; 2002 Feb; 273(2):138-46. PubMed ID: 11822869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced requirement of mitogen-activated protein kinase (MAPK) activity for entry into the S phase of the cell cycle in Swiss 3T3 fibroblasts stimulated by bombesin and insulin.
    Seufferlein T; Withers DJ; Rozengurt E
    J Biol Chem; 1996 Aug; 271(35):21471-7. PubMed ID: 8702930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.